A detailed history of Conway Capital Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Conway Capital Management, Inc. holds 31,925 shares of BSX stock, worth $2.89 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
31,925
Holding current value
$2.89 Million
% of portfolio
1.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$72.96 - $84.0 $2.33 Million - $2.68 Million
31,925 New
31,925 $2.68 Billion
Q4 2023

Dec 02, 2024

SELL
$48.64 - $57.81 $101,657 - $120,822
-2,090 Reduced 6.14%
31,925 $1.85 Billion
Q3 2023

Dec 02, 2024

SELL
$50.19 - $54.68 $169,391 - $184,545
-3,375 Reduced 9.03%
34,015 $1.8 Billion
Q2 2023

Dec 02, 2024

SELL
$49.72 - $54.64 $126,786 - $139,332
-2,550 Reduced 6.38%
37,390 $2.02 Billion
Q1 2023

Dec 02, 2024

SELL
$45.09 - $50.03 $119,488 - $132,579
-2,650 Reduced 6.22%
39,940 $2 Billion
Q4 2022

Dec 02, 2024

BUY
$39.56 - $47.22 $286,810 - $342,345
7,250 Added 20.51%
42,590 $1.97 Billion
Q3 2022

Dec 02, 2024

SELL
$36.71 - $109.66 $4,955 - $14,804
-135 Reduced 0.38%
35,340 $1.37 Billion
Q2 2022

Dec 02, 2024

SELL
$35.24 - $47.1 $19,382 - $25,905
-550 Reduced 1.53%
35,475 $1.32 Billion
Q1 2022

Dec 02, 2024

BUY
$40.9 - $45.1 $199,387 - $219,862
4,875 Added 15.65%
36,025 $1.6 Billion
Q4 2021

Dec 02, 2024

BUY
$38.07 - $44.87 $76,140 - $89,740
2,000 Added 6.86%
31,150 $1.32 Billion
Q1 2021

Dec 02, 2024

SELL
$35.27 - $39.67 $63,486 - $71,406
-1,800 Reduced 5.82%
29,150 $1.13 Billion
Q4 2020

Dec 02, 2024

SELL
$33.15 - $41.97 $32,321 - $40,920
-975 Reduced 3.05%
30,950 $1.11 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Conway Capital Management, Inc. Portfolio

Follow Conway Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conway Capital Management, Inc. with notifications on news.